CaliPharms, Inc. (KGET)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 4, 2026
CaliPharms Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2012 | FY 2011 | FY 2010 | 2009 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '14 Sep 30, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Jun '12 Jun 30, 2012 | Jun '11 Jun 30, 2011 | Jun '10 Jun 30, 2010 | 2009 - 2005 |
| Revenue | 0.11 | - | - | - | - | - | Upgrade
|
| Cost of Revenue | 0.14 | - | - | - | - | - | Upgrade
|
| Gross Profit | -0.03 | - | - | - | - | - | Upgrade
|
| Selling, General & Admin | 0.75 | 0.21 | 0.81 | 0.67 | 1.25 | 0.83 | Upgrade
|
| Operating Expenses | 0.75 | 0.21 | 0.81 | 0.67 | 1.25 | 0.83 | Upgrade
|
| Operating Income | -0.78 | -0.21 | -0.81 | -0.67 | -1.25 | -0.83 | Upgrade
|
| Interest Expense | -2.45 | -0 | -0.1 | -0.33 | -0.33 | -0.88 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.71 | - | - | - | - | -1.64 | Upgrade
|
| EBT Excluding Unusual Items | -5.93 | -0.22 | -0.92 | -1.01 | -1.57 | -3.35 | Upgrade
|
| Asset Writedown | -0.38 | - | - | - | - | - | Upgrade
|
| Pretax Income | -6.31 | -0.22 | -0.92 | -1.01 | -1.57 | -3.35 | Upgrade
|
| Earnings From Continuing Operations | -6.31 | -0.22 | -0.92 | -1.01 | -1.57 | -3.35 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -0.02 | - | -2.61 | Upgrade
|
| Net Income | -6.31 | -0.22 | -0.92 | -1.03 | -1.57 | -5.96 | Upgrade
|
| Net Income to Common | -6.31 | -0.22 | -0.92 | -1.03 | -1.57 | -5.96 | Upgrade
|
| Shares Outstanding (Basic) | 3,363 | 40 | 10 | 4 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 3,363 | 40 | 10 | 4 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 31942.59% | 285.84% | 150.09% | 32.66% | 94.34% | 465.65% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.09 | -0.24 | -0.50 | -3.66 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.09 | -0.24 | -0.50 | -3.66 | Upgrade
|
| Free Cash Flow | -0.72 | -0.05 | -0 | -0.21 | -0.14 | -0.59 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | - | -0.05 | -0.04 | -0.36 | Upgrade
|
| Gross Margin | -27.18% | - | - | - | - | - | Upgrade
|
| Operating Margin | -689.66% | - | - | - | - | - | Upgrade
|
| Profit Margin | -5612.48% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -641.48% | - | - | - | - | - | Upgrade
|
| EBITDA | - | - | - | - | - | -0.81 | Upgrade
|
| D&A For EBITDA | - | - | - | - | - | 0.02 | Upgrade
|
| EBIT | -0.78 | -0.21 | -0.81 | -0.67 | -1.25 | -0.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.